EDN1 and idiopathic pulmonary fibrosis: Of note, endothelin-1 and the coagulation cascade were believed to be implicated in the pathogenesis of IPF, while treatments with ambrisentan [181] and warfarin [182] were associated with even worse outcomes in IPF patients and should not be used for clinical use.